Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Predicting the affinity of halogenated reversible covalent inhibitors through relative binding free energy

Texto completo
Autor(es):
Lameira, Jeronimo [1] ; Bonatto, Vinicius [1] ; Cianni, Lorenzo [1] ; Rocho, Fernanda dos Reis [1] ; Leitao, Andrei [1] ; Montanari, Carlos A. [1]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Quim Sao Carlos, Grp Quim Med, NEQUIMED IQSC USP, BR-13566590 Sao Carlos, SP - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: Physical Chemistry Chemical Physics; v. 21, n. 44, p. 24723-24730, NOV 28 2019.
Citações Web of Science: 0
Resumo

Nitrile reversible covalent inhibitors of human cathepsin L (hCatL) bind covalently to the side chain of the catalytic Cys25 residue in the S1 pocket to form thioimidates. Predicting the binding of reversible covalent inhibitors is essential for their practical application in drug design. In this report, five nitrile-based inhibitors coded Neq0570, Neq0710, Neq0802, Neq0803 and Neq0804 had their hCatL inhibition constants, K-i, determined. These analogs of the prototypical Neq0570 are halogenated reversible covalent inhibitors of hCatL, which bear a halogen atom in the meta position of the P3 benzyl ring that can form a halogen bond with the Gly61 of the hCatL. To describe halogen bonding interaction in an inhibitor-hCatL complex, we applied an extra point (EP) of charge to represent the anisotropic distribution of charge on the iodine, bromine and chlorine atoms. Besides, we have used alchemical free energy calculations for evaluating the overall relative binding free energies of these inhibitors using a two-state binding model: noncovalent and covalent bond states. Our results show that free energy perturbation (FEP) can predict the hCatL binding affinities of halogenated reversible covalent inhibitors in close agreement with experiments. (AU)

Processo FAPESP: 13/18009-4 - Planejamento, síntese e atividade tripanossomicida de inibidores covalentes reversíveis da enzima cruzaína
Beneficiário:Carlos Alberto Montanari
Linha de fomento: Auxílio à Pesquisa - Temático
Processo FAPESP: 18/21749-3 - Estudo computacional da reação de inibição da enzima cruzaína por inibidores covalentes reversíveis
Beneficiário:Carlos Alberto Montanari
Linha de fomento: Auxílio à Pesquisa - Pesquisador Visitante - Brasil